(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD). (Q43191404)
Jump to navigation
Jump to search
scientific article published in August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD). |
scientific article published in August 2010 |
Statements
1 reference
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD). (English)
1 reference
Craig W Lindsley
1 reference
1 reference
Identifiers
1 reference